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a b s t r a c t 
Coronavirus disease 2019 (COVID-19) is largely threatening global public health, social stability, and econ- 
omy. Effort s of the scientific community are turning to this global crisis and should present future pre- 
ventative measures. With recent trends in polymer science that use plasma to activate and enhance the 
functionalities of polymer surfaces by surface etching, surface grafting, coating and activation combined 
with recent advances in understanding polymer-virus interactions at the nanoscale, it is promising to 
employ advanced plasma processing for smart antiviral applications. This trend article highlights the in- 
novative and emerging directions and approaches in plasma-based surface engineering to create antiviral 
polymers. After introducing the unique features of plasma processing of polymers, novel plasma strategies 
that can be applied to engineer polymers with antiviral properties are presented and critically evaluated. 
The challenges and future perspectives of exploiting the unique plasma-specific effects to engineer smart 
polymers with virus-capture, virus-detection, virus-repelling, and/or virus-inactivation functionalities for 
biomedical applications are analysed and discussed. 
© 2021 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license 


























Ever since the first outbreak of coronavirus disease 2019 
COVID-19) in December 2019, it took just a few months before 
t was declared a global pandemic in March 2020 [ 1 , 2 ]. DespiteAbbreviations: COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute 
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 079-670 0/© 2021 The Authors. Published by Elsevier B.V. This is an open access article unormous effort s dedicated to COVID-19 control, many countries 
re still suffering from the ongoing local transmission with a per- 
istent threat to the public health, social stability, and economy. 
he current pandemic is caused by a novel human coronavirus that 
s named severe acute respiratory syndrome coronavirus 2 (SARS- 
oV-2) [3] . Although not all mechanisms responsible for the spread 
f the virus are already fully understood, it is believed that cur- 
ent known routes for many other viruses are also applicable. Sim- 
lar to other viruses, SARS-CoV-2 spreads through virion-laden res- 
iratory droplets, direct contact, airborne aerosols, and contami- 
ated surfaces [ 4 , 5 ]. It is worth noting that surfaces in hospital
ooms of infected patients such as floors, bedside lockers, car- 
iac tables, and electric switches were found to contain coron- 
virus particles [ 6 , 7 ], which could be responsible for the nosoco- 
ial outbreak at the early stage of the pandemic [8] . Moreover, 
revious studies have demonstrated that various viruses, includ- 
ng SARS-CoV-2, can remain viable and infectious in aerosols for 
ours and on surfaces including plastics, stainless steels, copper, 
nd card-boards up to days [ 9 , 10 ], suggesting that surfaces such 
s food packages, clothes, transports, and building elements could 
lso impose potential threats during the pandemic period. In re- 
ponse, these high-touch surfaces are thus needed to be able to nder the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 























































































































) capture, b) detect, c) repel, and/or even d) inactivate viruses to 
rovide humans with the necessary protection from viral disease 
nfection. It is imperative to develop and fabricate antiviral sur- 
aces for an effective reduction and prevention of the spread of the 
urrent COVID-19 and for the prevention of the outbreak of future 
ovel virus-related pandemics. 
In particular, the COVID-19 crisis has raised the global need for 
he specialized polymeric materials for personal protective equip- 
ent (PPE) and virus-detection devices as they are indispensable 
t the forefront of fighting against SARS-CoV-2 and other infec- 
ious diseases. However, the commonly used polymeric materials 
enerally lack sufficient antiviral properties thus making front-line 
ealth-care workers vulnerable of being infected [11] . In litera- 
ure, one of the particularly crucial strategies to control infectious 
iseases is to exploit modern surface modification techniques to 
reate multifunctional materials with the desired ability to miti- 
ate the spread of infectious pathogens [12–14] . Considerable re- 
earch in the past decade has been conducted to combat bacterial 
athogens by antibacterial agent release, contact-killing, as well as 
nti-adhesion and bacteria-repelling surfaces [ 15 , 16 ]. However, lit- 
rature for a systematic study on broad-range antiviral surfaces is 
till scarce. Several reviews regarding antiviral surfaces have fo- 
used on either the performance of various antiviral agents or the 
irus-inactivation therapeutic tools [17–20] , but they generally fo- 
us on the specific surface engineering methods for engineering 
ntiviral surfaces. There is an emerging trend in developing inno- 
ative antiviral surfaces based on the well-established antibacterial 
xperience in the scientific community [17] . In this regard, high- 
ighting an effective and promising surface engineering technique 
ould thus be of critical importance for accelerating the related 
tudies. 
This trend article aims to highlight the state-of-the-art in the 
evelopment of antiviral surfaces using the diversified functionali- 
ies of the low-temperature plasma technology in polymer surface 
ngineering. Both focus and scope of this article differ from the 
vailable publications on the intrinsic (e.g. natural or biomimetic) 
ntiviral polymers used as antiviral therapeutics [21] and on 
lasma methods for surface functionalization of polymers [22] , 
lasma surface chemistry [23] , and antibacterial surface modifica- 
ion [ 24 , 25 ]. The distinctive feature of this article is in the sys-
ematic discussion of the possibility of processing common poly- 
ers with antiviral properties by plasma-based methods. Con- 
idering the virus as an object with a characteristic size at the 
anometres scale, one could use nanoscale structuring and func- 
ionalization of polymer surfaces to prevent the spread of viruses. 
s indicated in Fig. 1 , plasma structured and functionalized poly- 
ers with nanoscale features can be used for protecting humans 
rom virus infection by various antiviral strategies mainly includ- 
ng blocking the source of virions, breaking the spread pathways, 
nd protecting the susceptible hosts. Novel advances in plasma sur- 
ace engineering make the antiviral process non-toxic and environ- 
entally friendly. As a result, a healthier living and working envi- 
onment can be established that offers holistic solutions to people 
ith compromised or weakened immune systems. 
. Unique features of plasma processing of polymers 
Plasma is an ionized quasi-neutral gas known as the “fourth 
tate of matter” that consists of various charge carriers such as 
lectrons, ions, and reactive radicals. Among a variety of plasmas, 
on-thermal plasmas have been highly successful in the effective 
urface modification of polymeric materials for biomedical appli- 
ations [26] . 
Generally, by taking advantage of high-energy particles in plas- 
as, several common approaches of plasma-enabled physical and 
hemical surface modifications can be determined as (i) plasma 2 magnetron) sputtering; (ii) plasma etching; (iii) plasma activation; 
nd (iv) plasma-assisted deposition, etc. The schematic representa- 
ion of various types of approaches for plasma processing of poly- 
er surfaces is shown in Fig. 2 . Typically, plasma sputtering has 
een widely applied for the deposition of hard metallic and non- 
etallic coatings on flat materials [27] . Plasma etching has been 
idely used for the engineering of desired surface morphology 
ith precise control at the nanoscale [28] . In contrast, plasma acti- 
ation and plasma-assisted deposition processes can be employed 
or tailoring special surface chemistry combined with controlled 
urface morphology [ 22 , 29 ]. 
Importantly, these processes are versatile and can be oper- 
ted in broad process parameter windows including the frequen- 
ies of plasma power (e.g., from direct current (DC) to microwave 
MW) and lasers), electrode configurations, gas pressures from ul- 
rahigh vacuum to atmospheric, and spatial scales from atomic to 
esoscales [ 30 , 31 ]. Therefore, plasma surface processing allows the 
abrication of polymers to be scalable to almost any level with pre- 
ise control over surface morphology and chemical composition. 
oreover, the plasma-based approach is well-known as a solvent- 
ree technique, which is regarded as one of the most promising en- 
ironmentally friendly methods as an alternative to conventional 
et chemistry. The high-speed, stability, repeatability, low-cost, 
nd no damage to the bulk characteristics of treated polymers are 
lso vital advantages over other conventional surface modification 
ethods [32–34] . 
With recent advances in nanostructured biomaterials, these 
lasma methods have collectively emerged as an extremely ef- 
cient nanofabrication toolbox for polymer surface processing in 
iomedicine such as controlled drug release [33] , tissue engi- 
eering scaffolds [35] , and antibacterial surfaces [36] . Accordingly, 
lasma processing of polymers is expected to be one of the truly 
nique tools in the nanofabrication of antiviral materials under the 
urrent COVID-19 pandemic caused by the SARS-CoV-2 . Diverse 
lasma-based nanofabrication methods make it possible to provide 
ufficient flexibility to target viruses such as SARS-CoV-2. These 
iruses can be considered as core-shell particles with relatively fast 
utations [37–40] . The specific targets in this regard include dis- 
upting the spread pathways and affecting the surface-virus inter- 
ctions [4] . 
. Plasma processing of polymers to impact them with 
ntiviral properties 
Central to plasma processing of polymers to impart them with 
ntiviral properties is the enhancement of nanotexture formation, 
unctional groups grafting, and composite coating growth with tar- 
eted surface-virus interactions. This article aims to highlight the 
ain strategies and the most relevant recent trends in plasma- 
ssisted processing of polymer surfaces that can enable polymers 
ith antiviral properties. Therefore, some of the most relevant 
lasma-engineered polymer surfaces that could be extended for 
ntiviral applications are selected and discussed below. The sub- 
ections below represent the key strategies of plasma antiviral 
unctionalization of polymer surfaces, namely surface morphology 
 Section 3.1 ), surface chemistry ( Section 3.2 ), and composite coat- 
ngs ( Section 3.3 ). 
.1. Plasma processing of surface morphology 
In the last decade, considerable progress has been achieved in 
recise control of surface morphology by different plasma meth- 
ds, including plasma etching [ 41 , 42 ], plasma sputtering [43] , and
lasma-assisted deposition [44] . The surface properties such as 
ettability, adhesion, and mechanical performance that are highly 
ensitive to surface morphology can thus be precisely tailored to 
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Fig. 1. Graphic summary of options for plasma structured and functionalized polymer surfaces with nanoscale features to be used for protecting humans from viral infections. 
Plasma processing can be used to functionalize the high-touch surfaces, e.g., food packages, PPE, and some high-traffic objects such as doors and curtains in transports, 
homes, offices, and hospitals to protect people from getting infected. Moreover, plasma functionalized surfaces are promising to be used in smart antiviral applications, e.g., 
new virus biosensors with enhanced detection performance and novel self-sanitizing surfaces which involve some of the key antiviral processes including virus-capture, 
virus-detection, virus-repelling, and/or virus-inactivation. All these antiviral strategies meet the requirements of controlling infectious viral diseases by blocking the sources 












































































eet the high demand of desired applications in biology, energy, 
nd electronics [28] . For virus-related applicatons, the virus-laden 
espiratory fluid aerosols or droplets can range from < 10 μm to > 
00 μm in diameter (taking influenza A viruses as examples) [45] . 
owever, a virus is typically in the range of tens to hundreds nm 
n size, while the size of its features (such as viral spikes or bind-
ng domains) is much smaller that is in tens nm range. Accordingly, 
he antiviral surface response for targeting should be presented at 
he scales from nanometres to micrometres and even to millime- 
res when the prevention of virus spread pathways is tackled. 
Recent theoretical and experimental studies have suggested that 
he key to control respiratory virus transmission is to control the 
irus-containing aerosols or water droplets instead of the virus it- 
elf only [ 4 , 46–48 ]. Moreover, a positively charged nanofibrous mi- 
rofiltration membrane with hydrophilic properties functionalized 
y wet chemistry processes has demonstrated virus filters with en- 
anced performance that can meet the specific needs in the pu- 
ification of contaminated water [49] , showing the potential in the 
revention of human exposure even if aerosols or water droplets 
ere generated from the water [50] . Therefore, surfaces with the 
esired wettability can play a crucial role in controlling virus ac- 
ivities. More specifically, the use of hydrophilic surface function- 
lization with water contact angle (WCA) less than 3 ° has ensured 
he collapse of aspirated water droplets containing the MS2 bacte- 
iophage virus as shown for a bi-functional nano-composite coat- 
ng on a porous Nomex® fabric by a dip-coating method [51] . The 
tudy [51] has demonstrated that superhydrophilic fabric can be 
sed to separate the viruses from virus-containing water droplets 
nd prevent viruses from spreading in water droplets over a long 
istance. Furthermore, a recent model has shown that superhy- 
rophilic surfaces could be used to reduce the dry time of the 
irus-containing water droplets, and in the case of N95 mask/PPE 
odywear, a reduction in WCA to 10 ° can reduce the risk of getting 
OVID-19 infection by around 38% [52] . It has to be emphasized 
hat desiccation is an effective way for virus-inactivation as many 
urvival activities of viruses such as the assembly of membrane bi- 
ayers for the enveloped viruses could not maintain without wa- 
er [53] . Superhydrophilic surfaces are thus important during pan- 
emics such as COVID-19 to replace the mass use of chemical dis- 3 nfection solutions that could cause environmental pollution. How- 
ver, relatively little effort has been devoted to this field whereas 
uperhydrophilic surfaces specifically designed for antiviral appli- 
ations can be used as a complimentary approach to chemical dis- 
nfection. 
On the other hand, plasma technologies have been widely used 
or tailoring surface wettability of polymer surfaces, which pro- 
ides ideal tools for relevant studies. Representative examples 
f plasma nanotexturing polymer surfaces with superhydrophilic 
roperties are present in Fig. 3 (a) [54] . A forest of nanopillars 
ith a number density of 39 ± 8 μm −2 on polycarbonate (PC) sur- 
ace can be observed at 20 min of 100 W oxygen plasma surface 
tching which induced a pronounced hydrophilic behaviour with 
alues of 12 ° and 3 ° on the surface for the advancing and reced- 
ng WCA, respectively. It is worth noting that such plasma etched 
olymer surfaces were subjected to a typical hydrophobic recovery 
ith advancing WCA reaching 78 ° and receding WCA reaching 19 °
t 21 days after the processing [54] . However, when it was cov- 
red by a thin layer of the silica-like coatings by plasma-assisted 
eposition, the advancing WCA and receding WCA were slightly 
hanged to 4 ° and 2 °, respectively, and the superhydrophilicity of 
he covered coating was preserved for as long as 5 months [54] , 
hich is promising for practical applications. 
Likewise, superhydrophobic surfaces with the abilities to re- 
el water droplets could also be targeted in some practical an- 
iviral applications [55] . Recently, superhydrophobic surfaces with 
iral repellence properties have been achieved using polytetraflu- 
roethylene (PTFE) nanoparticles by a wet chemistry approach 
hrough a thermal sintering in a liquid phase to polypropylene (PP) 
icrofibers [56] . The coated textiles reduce the attachment of ade- 
ovirus type 4 and 7a virions by 99.2 ± 0.2% and 97.6 ± 0.1% (2.10 
nd 1.62 log), respectively, as compared with the non-coated con- 
rols. The outstanding performance can be attributed to the Cassie- 
axter state of wetting, a state where a liquid drop is located on 
op of a surface’s rough features and traps pockets of gas between 
hese features, leading to a very high WCA greater than 150 ° and a 
ery low WCA hysteresis below 10 ° with water repellent and self- 
leaning characteristics [ 57 , 58 ]. However, the environmental pol- 
ution level during the fabrication steps using solvents as used in 
C. Ma, A. Nikiforov, N. De Geyter et al. Progress in Polymer Science 118 (2021) 101410 
Fig. 2. Schematic representation of typical approaches for plasma processing of polymers. (a) plasma (magnetron) sputtering, (b) plasma etching (taking reactive ion etching 










































56] are quite high. Moreover, a recent study has shown that the 
aser-fabricated graphene-coated masks with outstanding superhy- 
rophobic and photo-thermal performance are self-cleaning and 
eusable after sunlight sterilization [59] . However, such a method 
s very costly and only applicable at a small-scale without perspec- 
ive for industrial-scale application, and more importantly, laser- 
nduced surface modification of polymers may cause bulk damage 
o the material. 
Plasma fabricating methods , on the other hand, are viable alter- 
atives to the laser-based approaches. Superhydrophobic surfaces 
an be achieved by oxygen plasma etching combined with plasma- 
nhanced chemical vapour deposition (PECVD) using hexamethyl- 
isiloxane (HMDSO) as the precursor ( Fig. 3 (b)) [60] . Importantly, 
he surfaces are also in a Cassie-Baxter state, which can result in 
harp bouncing when hit by water droplets at high impact velocity 
see Fig. 3 (b) (iii)) [60] . Such surfaces prepared by plasma meth- 
ds represent a class of polymers with water repellent and self- 
leaning characteristics [61] and can theoretically be used to repel 
hose respiratory viruses such as the above-mentioned influenza A 
nd SARS-CoV-2 that mainly spread through virion-laden droplets. 
hese polymer surfaces should be of high importance for medical 
quipment, protective clothes, and respiratory masks [55] . i
4 Plasma engineered nanopatterned surfaces. In many cases, the re- 
uired morphology of a surface for many advanced applications 
s inspired by nature where nanotexturing of the materials is of- 
en a case for plants, animals, and insects [64] . The new trends 
n mimicking biological surfaces have led to the development of 
ovel surfaces with unique properties. It has been reported that 
he topography of dragonfly wing surfaces has a bactericidal effect 
n Escherichia coli [65] . Similar behaviour of plasma engineered 
anopatterned surfaces has been obtained by tetrafluoromethane 
CF 4 ) / hydrogen (H 2 ) plasma texturing on a Si surface [66] . More-
ver, some biomimetic plasma nanopatterned polymer surfaces 
ave been demonstrated to convey bactericidal efficacy [67] . The 
echanisms of bactericidal activity are mainly attributed to the 
tressing mechanical killing by nanostructured surfaces, known as 
ontact-killing [ 68 , 69 ]. Despite the well-studied antibacterial ef- 
ects, experimental evidence of the antiviral functionality of such 
olymer surfaces is rare. Viricidal effect of nanotexturing polymers 
hould be investigated in the future. 
Considering the difference between the bacteria and viruses 
egarding the structure and size, the requirement on the size 
nd density of the nanostructured polymers for disabling viruses 
an be very high. Plasma fabrication can provide high flexibil- 
ty in polymer morphology for subsequent research on antivi- 
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Fig. 3. Representative examples of plasma processing of polymers with controlled surface morphologies. (a) Superhydrophilic PC surface prepared by plasma etching. The 
scale bar is 1 μm. [54] , Copyright 2011. Adapted with permission from John Wiley & Sons Inc. (b) A Cassie-Baxter state robust superhydrophobic PC surface obtained by 
oxygen plasma etching combined with PECVD using HMDSO as the precursor:(i) Surface morphology, (ii) WCA image showing WCA > 170 °, and (iii) the sharp bouncing 
behaviour when hit by 3 μL water droplets at an impact velocity of 1.1 m/s. The scale bars in (i) and (iii) are 1 μm and 1 mm, respectively. [60] , Copyright 2014. Adapted 
with permission from Elsevier. (c) Plasma etching of polymer nanowires with controlled density and length. The figure shows examples of Kapton nanowires by covering 
the initial surface with 15 nm Au before plasma treatment. The scale bar is 1 μm. [62] , Copyright 2009. Adapted with permission from the American Chemical Society. (d) 
Surface morphologies of ZnO nanowires grown on channel diffused plasma modified regions of PDMS substrate at different magnifications. The scale bars are 2 μm. [63] , 

































































al activities. For example, plasma-assisted methods of deposi- 
ion can provide sufficient flexibility in the fabrication of dense 
olymer nanowires with a typical length up to 7-8 μm [70] . 
ne-step plasma etching of polymer films covered with a thin 
ayer of metal nanoparticles has been demonstrated to fabricate 
arge-scale polymer nanowire arrays of any organic materials, with 
easonable control over the density and length ( Fig. 3 (c)) [62] . 
etal oxide nanowires can be fabricated using oxygen plasma site- 
elective surface modification combined with wet chemistry on 
olydimethylsiloxane (PDMS) surfaces with desired control over 
he growth position ( Fig. 3 (d)) [63] . 
Recently, it has been reported that 23 nm wide nanostructures 
andomly aligned as ridges on aluminium surfaces engineered by a 
et etching technique exhibited both antibacterial and antiviral ef- 
ects that are promising for clinical applications [71] . In the study 
71] , common respiratory viruses, respiratory syncytial virus (RSV) 
nd rhinovirus (RV) have been tested on the fabricated nanoscale 
urfaces, and the surfaces have significantly reduced the amount 
f viable RSV recovered as compared with the control surfaces. 
he structured surfaces were more effective in preventing RV than 
SV infection. In the case of RV, there was a 3 −4 log reduction
bserved in viable viruses after 24 h, showing the ability of the 
anosurfaces to reduce the potential for surface contact transmis- 
ion of diseases [71] . Even though it is extremely difficult to ex- 
loit such kind of wet etching technique to nanotexture the widely 
sed polymeric materials in the desired manner as it is hard to 
ontrol and may contaminate the treated polymers [72] , the study 
71] provides evidence about the viricidal effect of nanostructured 
urfaces. Therefore, we believe that the versatile plasma fabrica- 
ion approaches with controllable properties could play a vital role 
n fabricating similar or even better nanopatterned polymeric an- 
iviral surfaces, and the relevant studies should be carried out im- 
ediately. 
It should be noticed that the mechanism of virus reduction is 
till unclear. One possible mechanism can be similar to the bac- 
ericidal effect of nanostructured surfaces. We can thus infer that 
lasma-fabricated nanowires deposited on a polymer surface could 
b
5 ave certain antiviral efficiency if their sizes and dimensions could 
atch the characteristic dimensions of the viruses. Another pos- 
ible mechanism is attributed to the physical adsorption of viruses 
n surfaces, as the process is a function of surface area and surface 
ctivity [51] . 
It should also be emphasized that bacterial infection is a typical 
omplication of viral infections [ 73 , 74 ]. Therefore, surfaces com- 
ined with both bactericidal and viricidal effects are necessary and 
an be fabricated using plasma-based approaches that could result 
n multifunctional polymers. 
There is no doubt that current advances in fabricating the de- 
ired wetting and nanopatterned polymer surfaces as antiviral ma- 
erials are not sufficient and many observed effects are not yet 
ully understood. There is a trend and a strong need to employ 
ersatile plasma techniques to tailor surface morphology to tar- 
et viruses including the novel COVID-19 type. More specifically, 
he wettability control for desiccating or repelling virus-containing 
roplets and the nanostructured surface interactions with viruses 
hould be one of the foci in both plasma technology and polymer 
cience. 
.2. Plasma processing of surface chemistry 
Plasma methods of processing polymer surfaces can target the 
orphology of the polymers and provide a convenient way to reg- 
late the chemical composition of the surfaces, which may play a 
rucial role in the development of a new class of antiviral materi- 
ls. Variation of the polymer surface chemistries by plasma func- 
ionalization can result in surface properties with the desired wet- 
ability and specific functional groups without altering its mechan- 
cal properties. 
As discussed in Section 3.1 , the control of surface wettability 
s one of the important antiviral strategies. Targeted surface wet- 
ability can also be achieved by tailoring surface chemistry using 
lasma approaches. As it is known, surface hydrophilicity induced 
y plasma activation generally shows a hydrophobic recovery that 
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Fig. 4. Representative examples of plasma engineering polymers with controlled surface chemistries. (a) Superhydrophilic surfaces by plasma-polymerized TEOS- 
O 2 /CH 4 /PDMS with long-term stability. The inset shows WCA ~ 0 ° and the scale bar shows 1 μm. [75] , Copyright 2012. Adapted with permission from Elsevier. (b) One-step 
production of rough superhydrophobic plasma coatings with WCA = 167 ° using He gas plasma containing 0.3 vol % benzene + cyclohexane (8:2) mixture on a flat Si wafer 
substrate. The scale bar shows 300 nm. [81] , Copyright 2011. Adapted with permission from the American Chemical Society. (c) Bacterial proliferation in REF sample (i) and 

































































s caused by the reorganization of chemical polar groups to mini- 
ize the surface energy. 
Multi-layer plasma depositions , however, can be considered as 
ne of the most promising strategies that can overcome such prob- 
ems. Fig. 4 (a) shows the stable superhydrophilic surfaces fabri- 
ated by such multi-layer plasma depositions [75] . In [75] , the hy- 
rophobic PDMS block firstly covered by a layer of CH 4 plasma 
oating was then overlaid by hydrophilic SiO x layer using tetraethyl 
rthosilicate and oxygen (TEOS-O 2 ) precursors. This approach pro- 
ided superhydrophilic properties of the polymer surface for over 
8 days. The highly cross-linked hydrocarbon layer acted as a phys- 
cal barrier between the bare PDMS surface and the hydrophilic 
ayer, which possibly hindered the reorganization and migration of 
hemical polar groups and resulted in the surface that remained 
table over a long time. 
Similarly, stable superhydrophilic surfaces can also be obtained 
y Ar plasma post-treatment of plasma polymerized HMDSO coat- 
ngs in the atmospheric-pressure roll-to-roll system that is promis- 
ng to be scaled-up for industrial applications [76] . It is worth em- 
hasizing that due to the diversities of plasma reactor configura- 
ions [77] , it is promising to integrate the existing or newly de- 
igned atmospheric-pressure plasma reactor into the existing roll- 
o-roll industrial production line. Typical examples with the poten- 
ial for mass production of the desired antiviral polymers are pre- 
ented in the literature [78–80] . 
Recent years have also witnessed major advances in the fabrica- 
ion of superhydrophobic surfaces using the plasma-assisted mod- 
fication of surface chemistry. As surface wettability is determined 
y surface chemistry and surface microstructures, it is extremely 
ifficult to achieve superhydrophobicity in a single-step process us- 
ng conventional fabrication strategies. 
Plasma polymerization, one of the most important plasma tech- 
iques is based on the fact that the formation of particles is highly 
ependent on the nature of the precursor monomer and occurs 6 ith the assistance of the reactive species in plasmas to induce 
ondensation reactions in the gas phase. Therefore, it allows a 
ne-step process for tailoring both surface chemistry and surface 
oughness simultaneously. Fig. 4 (b) indicates that one-step pro- 
uction of a rough superhydrophobic plasma coating with WCA of 
67 ° using He gas plasma containing 0.3 vol % benzene + cyclohex- 
ne (8:2) mixture on a flat Si wafer substrate [81] . Similar super- 
ydrophobic coatings on different substrates including gold film, 
imwipe, and cotton have also been achieved using He-CF 4 -H 2 
lasma at atmospheric-pressure [82] . In addition to these chem- 
cals mentioned above, precursor monomers containing alkyl- or 
uoroalkyl- groups that can lead to surface hydrophobicity, such as 
MDSO (O[Si(CH 3 ) 3 ] 2 ) [83] , 1H,1H,2H,2H-perfluorododecyl acrylate 
C 13 H 7 F 17 O 2 ) and dodecyl acrylate (C 15 H 28 O 2 ) mixture [84] have
lso been investigated intensively for producing superhydrophobic 
urfaces by the method of plasma polymerization. 
We emphasize that some of the hydrophobic surfaces tailored 
y plasma fabrication may not only repel the virus-containing wa- 
er droplets for some antiviral applications (as described above) 
ut also play a crucial role in inactivating viruses themselves. A 
revious study has demonstrated that surfaces that are simultane- 
usly hydrophobic and oleophilic are efficient in inactivating in- 
uenza A viruses (e.g. for the surface with WCA = 111 ° and hexade- 
ane contact angle = 45 ° simultaneously, the infection degree can 
e reduced to below 30%) due to the disruption of the viral mem- 
rane upon its contact with the alkyl chains coated on the glass 
urfaces [86] . More importantly, nanostructured surfaces with the 
nhanced highly hydrophobic and oleophilic behaviour induced by 
he plasma (reactive ion) etching can increase the inactivation ef- 
ects (e.g. the surface with WCA = 154 ° and hexadecane contact an- 
le = 26 ° simultaneously can lead to a dramatic reduction in the 
nfectivity level of influenza A viruses to below 10%) [86] . Indeed, 
hen some of the virus-containing water droplets failed to be re- 
elled by the functionalized hydrophobic surfaces, such kind of hy- 



























































































































rophobic “contact-killing” surfaces could play a role of “the sec- 
nd line of defence” to inactive the attached viruses. 
Another type of the known contact-killing microbicidal surfaces 
unctionalized by specific surface chemistry is the polymeric coat- 
ngs comprising hydrophobic polycations such as branched or lin- 
ar N, N -dodecyl methyl-polyethylenimines and their derivatives 
hat have shown the capacity to kill influenza A virus with essen- 
ially a 100% efficiency (at least a 4 log reduction in the viral titer) 
ithin minutes, as well as the airborne human pathogenic bacte- 
ia Escherichia coli and Staphylococcus aureus [87] . Generally, these 
olyethylenimines-based coatings are hydrophobic and positively 
harged, when viruses owning an inherent negative charge (e.g. in- 
uenza A virus) strike the coated surface due to thermal motion, 
he hydrophobic and electrostatic interactions will make viruses 
dhere to the surface and then lead them towards inactivation by 
estroying their genomic content or structures [ 88 , 89 ]. Typically, 
hese hydrophobic polycations are either covalently attached or de- 
osited onto surfaces of diverse materials and regarded as non- 
eaching, permanently microbicidal coatings with promise for re- 
lacing these toxic and easy to be exhausted biocide release prod- 
cts [88] . However, fabricating these covalently modified antiviral 
urfaces by wet chemistry generally requires harsh reaction condi- 
ions, multi-step processes, and specific substrates [ 88 , 90 ]. 
Atmospheric-pressure aerosol-assisted plasma deposition has been 
roposed as a direct and substrate-independent approach to fab- 
icate N, N -hexyl,methyl-polyethylenimine coatings for virucidal 
gainst human influenza A virus with a reduction of greater than 
 log [90] . Importantly, the coatings have shown thermal stability 
up to 150 °C) and durability upon exposure to vigorous washes and 
xposure to detergents. However, the relevant studies still remain 
t the early stages and a combination of both plasma-based ap- 
roaches and polyethylenimines-based chemistry should be inves- 
igated and applied for more kinds of viruses beyond the influenza 
 virus. 
Chemically active plasma-assisted coatings are proposed as an- 
ther strategy in the development of antiviral polymers based on 
he engineering layers capable of releasing reactive oxygen and 
itrogen species (RONS). Indeed, it is known that RONS play a 
ital role in cancer treatment [91] , antibacterial [92] and virus- 
nactivation [93] . Therefore, active materials capable of generating 
ONS are considered as a new trend in virus-inactivation. Some of 
hese materials are based on the coatings that integrate photosen- 
itizers and photocatalysts capable of RONS generation under light- 
ctivation that results in antimicrobial efficiency with multiple ad- 
antages including high biocidal effect, broad-spectrum antimicro- 
ial action, and low toxicity with little environmental concern [94] . 
anofibrous membranes grafted with the designed photosensitizer 
olecules based on benzophenones and polyphenols by wet chem- 
stry approaches have shown the ability to release RONS such as 
ydroxyl radicals ( • OH), superoxide ( • O 2 −), and hydrogen perox- 
de (H 2 O 2 ) [95] . This ability was activated by the daylight, showing
ontact-killing of both Gram-negative Escherichia coli O157:H7 and 
ram-positive Listeria innocua bacteria (efficiency > 99.9999%) and 
7 bacteriophage viruses (efficiency > 99.999%) either in aerosol 
r liquid form [95] . The materials are quite promising to pro- 
uce PPE with the desired antiviral functions. However, such kinds 
f photosensitizer-based RONS agent release coatings prepared by 
lasma processing of surface chemistry for both antibacterial and 
ntiviral applications are still rare and are thus worth to be inten- 
ively investigated. 
In addition to these RONS virucidal agents, RONS could also 
e effective for stimulating immune responses against viruses in 
he patients [19] . Hence, RONS release coatings can be used as 
rug delivery systems. One important such type of RONS is ni- 
ric oxide (NO) that is a critical messenger molecule in biologi- 
al systems and has been applied in biofilm inhibition and dis- 7 ersal [96] , vasodilatation [97] , and stem cell behaviour modifi- 
ation [98] . More importantly, NO has shown the high efficiency 
f antibacterial activities [96] and antiviral effect by improving ar- 
erial oxygenation and enabling the reduction of inspired oxygen 
herapy and airway pressure support in patients carrying SARS 
r COVID-19 [ 99 , 100 ]. It has been reported that plasma polymer- 
zed isopentyl nitrite (IPNpp) coatings on polyethene terephthalate 
PET) surfaces can be successfully used for NO release at bacte- 
iostatic concentrations, inhibiting bacterial ( Staphylococcus epider- 
idis ) growth without cytotoxic side effects to human mesenchy- 
al stem/stromal cells, the bacteria in the reference (REF) sample 
ontinued to multiply and form biofilms and in contrast, bacteria 
eing in contact with the IPNpp neither multiplied nor formed any 
isible biofilm even after 14 h incubation ( Fig. 4 (c)) [85] . Similarly,
recursor monomers such as allylamine and diallylamine have also 
een used for plasma polymerization to load NO that enables ex- 
ellent cell-surface interactions and continuous release of NO over 
8 h [101] . The plasma polymerization approach allows the forma- 
ion of stable amine polymers with targeted surface anchoring sites 
or loading the NO molecular which can avoid potentially carcino- 
enic amine decomposition products. 
We emphasize that the antiviral mechanisms of NO are quite 
ifferent from the antibacterial mechanisms. As a highly reactive 
ree radical, NO may be a modulator of host response against nu- 
erous viruses [ 102 , 103 ] but may have the opposite effects in dis-
ases caused by viral infections such as influenza A virus pneu- 
onia and certain other neurotropic virus infections. However, a 
ecent study has shown that acute respiratory distress, caused by 
he inflammatory cascade inside the lungs, is the leading cause of 
OVID-19 case-fatality [104] . Thus, NO may soak up cellular signals 
hat enhance inflammation, which is an important factor for antivi- 
al protection against the current pandemic. Despite the promising 
herapeutic potential of NO, the delivery of NO remains a challenge 
ue to its reactive nature and short half-life in the biological me- 
ia (typically in the order of seconds). Plasma polymerization of 
O release coatings could thus be one of the viable candidates for 
he delivery of the NO molecules to the infected loci with the con- 
rolled release amount and release time. The relevant antiviral ef- 
ects and in-depth mechanisms of the NO release coatings are thus 
lso needed to be urgently investigated. On the other hand, it also 
eeds to investigate the collective strategies by combining the ef- 
ective antibacterial effects of NO and other antiviral strategies to 
revent the spread of viruses in the environment and reduce con- 
urrent bacterial infections caused by viral infections. 
.3. Plasma processing of composite coatings 
Materials-centred approaches that impart antiviral properties 
nto a polymer surface are also focused on the processing of 
omposite coatings by integrating the desired biomolecules or an- 
iviral drugs/agents into the coating structure. Such techniques 
re truly versatile in enabling different surface-virus interactions. 
lasma-based approaches are also known for the engineering of 
omposite coatings in a controllable and spatially selective man- 
er [105] , which could be highly promising for the nanofabrica- 
ion of antiviral polymers. Various strategies with typical exam- 
les of plasma processing of composite coatings, including surface- 
mmobilized bioactive compounds and antiviral drug/agent release 
oatings, that can be applied for impacting polymers with antivi- 
al properties are discussed below. 
.3.1. Surface-immobilized bioactive compounds 
It is known that the multivalent interactions between viruses 
nd their protein receptors on host cells such as interactions be- 
ween SARS-COV-2 and angiotensin-converting enzyme 2 (ACE2) 
re the primary step during virus infection [106] . Therefore, 
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Fig. 5. Representative examples of plasma-assisted surface-immobilized bioactive compounds. (a) Two plasma-based approaches (PECVD and plasma grafting of PFM) for BSA 
protein-immobilization. The left plot indicated that the variation of the dissipation ( D) vs the frequency shift ( f) showing a higher increase in the viscoelastic properties 
per mass unit attached on the grafting PFM-modified surface. The right bar graph showed the final value of the D/ f ratio confirming that the protein layer formed by 
PECVD was more rigid and thus had lower water content. [108] , Copyright 2013. Adapted with permission from the American Chemical Society. (b) Plasma immersion ion 
implantation for antimicrobial peptide immobilization. The results showed that the bacteria adhesion on the covalently attached melimine-coated surface was significantly 



































































rotein-immobilization on the polymeric materials could be re- 
arded as one of the antiviral strategies given the specific inter- 
ctions between a particular protein and its specific binding viral 
arget. During the last decade, multiple plasma-assisted methods of 
urface modification and activation have been employed to create 
olymers with surface functional groups that can covalently attach 
any types of biomolecules [107] . 
Protein-immobilized surfaces can be one of the important an- 
iviral materials due to their specific interactions with targeted 
iruses. Fig. 5 (a) presents a typical example of two plasma- 
ased approaches for protein-immobilization [108] . Both PECVD 
nd plasma grafting using pentafluorophenyl methacrylate (PFM) 
s monomers were investigated to functionalize polystyrene (PS) 
trips surfaces with reactive ester groups. Such functional groups 
re highly reactive toward amines, and allow the covalent bonding 
f bovine serum albumin (BSA) proteins to the surfaces in different 
anges (200 ng • cm –2 for PECVD, 100 ng • cm –2 for plasma grafting of
FM) [108] . Importantly, both approaches can maintain the bioac- 
ivity of the immobilized proteins despite that PECVD can result 
n more conformational changes than those induced by the plasma 
rafting approach [108] . Similarly, various monomers such as ally- 
amine [109] and ethylenediamine [110] , and various reactive gases 
uch as oxygen [111] and ammonia [112] were also used as reactive 
hemicals in plasma polymerization or plasma activation processes 
or the immobilization of various proteins including antigens and 
ntibodies. 
It should be emphasized that some of the antibody- 
mmobilization surfaces prepared by plasma technology have 
lready been employed for virus-capture. Anti-influenza A virus 
emagglutinin antibody was anchored via N -succinimidyl 3-(2- 
yridyldithio) propionate on the surface of graphite-encapsulated 
agnetic beads functionalized by radio frequency (RF) ammonia 
lasma, and the infectivity of captured viruses was maintained, 
howing that this method is useful for the enhanced detection and 
solation of influenza A virus [112] . On the other hand, a recent 8 tudy has revealed that the single-domain antibodies isolated 
rom a llama immunized with the prefusion-stabilized middle 
ast respiratory syndrome (MERS-CoV) or SARS-CoV coronavirus 
pikes can be used for neutralizing MERS-CoV or SARS-CoV spike 
seudo-type viruses, respectively, showing the promise for the 
reatment of diseases caused by coronaviruses including SARS- 
oV-2 [114] . There is no doubt that polymer surfaces with such 
inds of antibodies engineered by plasma technology could also 
e potentially used for targeting a specific virus. 
The antiviral peptide immobilized surface is another important 
ype of bioactive materials that can be applied for fighting against 
iral infections. Generally, antimicrobial peptides are produced by 
ll microorganisms, plants, and animals as a part of the innate 
mmune response, and display a broad-spectrum of antibacterial, 
ntifungal, and antiviral activities [ 115 , 116 ]. Indeed, antiviral pep- 
ides play a vital role in fighting against various virus infections 
 117 , 118 ]. Fig. 5 (b) illustrates an example of a plasma-based ap-
roach for the immobilization of antimicrobial peptides on poly- 
er surfaces [113] . In this example, plasma immersion ion implan- 
ation was adopted as a linker-free single-step treatment that co- 
alently coupled antimicrobial peptides to polyvinyl chloride (PVC) 
atheter, showing strong antimicrobial activity demonstrated by 
igher than 3 log kill of Staphylococcus aureus [113] . Similarly, 
xygen plasma treatment of silicone surfaces has been regarded 
s a straightforward strategy to immobilize antibacterial peptides 
n a site-specific way with excellent antibacterial activities [119] . 
urfaces functionalized by argon plasma activation followed by 
ilanization or plasma polymerized allyl glycidyl ether coatings 
ere also investigated in-depth for the immobilization of antimi- 
robial peptides [ 120 , 121 ]. It has been revealed that the key point
f surfaces functionalized by plasma is the specific reaction be- 
ween surface functional groups and the chemical composition of 
argeted bioactive compounds. 
Therefore, it is reasonable to transfer from antibacterial towards 
ntiviral surfaces by the fabrication of composite coatings contain- 























































































































ng antiviral peptides for antiviral applications, as the chemical 
omposition for antibacterial peptides is similar to that of antivi- 
al peptides. Moreover, a recent study has revealed that two types 
f cellular polymeric sponges made of the derivatives from human 
ung epithelial type II cells or human macrophages displayed the 
ame protein receptors, both identified and unidentified, required 
y SARS-CoV-2 for cell entry, and can be used as effective med- 
cal countermeasures against SARS-CoV-2 infection [122] . As the 
lasma-based approach is both scalable and flexible, it is promis- 
ng to apply plasma technology for the mass production of such 
inds of polymeric nanoparticles with bioactive compounds. Nev- 
rtheless, all such antiviral applications should be investigated in- 
epth both in theory and in practice. 
.3.2. Antiviral drug/agent release coatings 
Recently, major attention has been paid to the controlled 
rug/agent release polymeric coatings as they are regarded as 
uccessful tools to modulate surface properties of biomaterials, 
amely tissue responses and fouling behaviour [ 123 , 124 ]. Specifi- 
ally, plasma treatment is a novel and advanced method that can 
lay a crucial role in this emerging research area [125] . Differ- 
nt from the aforementioned “contact-binding” strategy through 
lasma-enabled immobilization of bioactive compounds and virus- 
ecognition, composite drug release coatings aim to inactivate spe- 
ific viruses by releasing antiviral drugs/agents from the polymeric 
oatings in a controlled way. Generally, several plasma-based ap- 
roaches can be applied to fabricate such coatings with specific 
rugs/agents, as presented in Fig. 6 . 
Aerosol-assisted plasma deposition represents a typical example 
f a process for preparing drug release coatings. As depicted in 
ig. 6 (a), water containing antimicrobial drugs Gentamicin was 
njected in the form of an aerosol into a dielectric barrier dis- 
harge plasma through an atomizer, the ethylene gas was added 
s a precursor of the matrix simultaneously [126] . With the assis- 
ance of the non-thermal plasma, the drug molecules were suc- 
essfully incorporated into the plasma polymers without altering 
heir chemical structure, and the embedded drug showed excellent 
ntibacterial effects with the controllable release [126] . This single- 
tep procedure performed at the atmospheric-pressure is quite at- 
ractive and can be scalable to meet the industrial demands. Im- 
ortantly, the aerosol-assisted plasma deposition process can keep 
he bioactivity of the drug molecules unchanged due to the mild 
ragmentation conditions as featured by the atmospheric-pressure 
lasma and the shield of the drug by a thin protective solvent shell 
hat preserves its structure and functionality [ 126 , 130 ]. Moreover, 
erosol-assisted plasma deposition also shows excellent versatil- 
ty, as various drugs or bioactive molecules (including proteins and 
eptides mentioned above) such as Vancomycin and Lysozyme have 
lso been investigated in-depth for biomedical applications [131–
33] . 
Multi-steps plasma surface engineering processes, in addition to 
he single-step plasma process for drug release coatings, present 
nother important strategy to achieve improved drug release per- 
ormance. As indicated in Fig. 6 (b), air plasma activation of 
olypropylene (PP) surgical meshes were firstly adopted to in- 
rease the drug-loading capacity (nearly 3-fold higher Ampicillin 
oading after 3.5 s treatment), followed by polyethene glycol (PEG)- 
ike coatings using tetraethylene glycol dimethyl ether as the pre- 
ursor under a low-pressure RF plasma condition [127] . It allowed 
ombining higher drug-loadings and maintaining essentially un- 
hanged fibroblast properties such as chemotaxis or adhesion with 
espect to untreated PP meshes. 
Therefore, there is no doubt that combined with the rapid de- 
elopment of antiviral drugs, plasma techniques could be promis- 
ng for the production of antiviral drug release coatings even 
hough relevant antiviral studies are currently rare. 9 Although specific reactions between viruses and antiviral drugs 
nsure the high efficiency of virus-inactivation, antiviral materi- 
ls need to have a broad-spectrum activity to enable their bind- 
ng or interacting with the mutated viral spike as viruses have al- 
ays been evolving, e.g. the mutation of SARS-CoV-2 spike may 
otentially produce more aggressive coronaviruses [40] . Functional 
etal-based nanoparticles including Cu, Au, Ag, TiO 2 have shown 
road-spectrum antiviral activities [ 134 , 135 ]. A recent study has 
hown that Cu 2 O nanoparticles embedded into polymeric coatings 
an inactive SARS-CoV-2 with about 99.9% reduction of viral titer 
n average as compared with the uncoated sample [136] , implicat- 
ng that metal-based nanoparticles may inactivate unknown and 
nderstudied viruses given their broad virus binding spectrum. As 
 versatile technique, the aforementioned aerosol-assisted plasma 
eposition can also be applied to dope polymeric coatings with an- 
iviral metal-based nanoparticles [ 137 , 138 ]. 
Plasma sputtering, as a recent example, has been employed 
n a configuration of the gas-aggregation plasma sputtering sys- 
em for the production of composite surfaces with the capabil- 
ty of metal ions release (such as Pt, Ti and Al) and hydropho- 
ic/superhydrophobic behaviour ( Fig. 6 (c)) [ 128 , 129 ]. Such sur- 
aces are expected to fight against infections due to the surface 
ydrophobicity/superhydrophobicity and the broad-spectrum an- 
ibacterial/antiviral activities of the nanoparticles. It should be em- 
hasized that plasma technology can be employed to functionalize 
ot only polymer surfaces but also metal/metal oxide nanoparticles 
e.g. ZnO, Al 2 O 3 , and ZrO 2 in [139] ) with specific functional groups 
r bioactive compounds to enhance their antiviral effect. Im plant- 
ng the functionalized nanoparticles into the fabricated polymeric 
oatings (by e.g. the gas-aggregation plasma sputtering system) can 
roduce highly desired materials for inactivation of the targeted 
irus. 
Considering the extreme complexity of virus inhibition and the 
ariability of the viruses, employing plasma techniques for prepar- 
ng composite antiviral materials is expected to grow as an effec- 
ive antiviral material engineering strategy in the future thus form- 
ng a new trend at the interface of polymer science, plasma sci- 
nce, biology and medicine. 
. Future trends in smart polymers for antiviral applications 
As discussed in Section 3 , non-thermal plasmas generate active 
hysical and chemical species which make them of considerable 
alue in the production of advanced materials with antiviral prop- 
rties. Further applications of such materials should be sufficiently 
mart to involve some of the key processes including virus-capture, 
irus-detection, virus-repelling, and/or virus-inactivation. To illus- 
rate the potential utility of non-thermal plasmas, below this arti- 
le highlights the selected further trends in the emerging antiviral 
pplications that are most relevant to plasma polymer processing. 
.1. Plasma-enhanced performance of virus biosensors 
Early diagnosis and management of virus spread are crucial for 
onstraining the spread of infectious viral diseases such as COVID- 
9 [ 48 , 140 ]. Currently, real-time reverse transcription-polymerase 
hain reaction (RT-PCR) is the primary approach for emerging 
athogen diagnosis. However, the protocol of RT-PCR involves mul- 
iple steps, and errors in any of these steps such as the DNA/RNA 
reparation could affect the diagnostic accuracy [ 141 , 142 ]. Hence, 
he development of advanced highly sensitive immunological diag- 
ostic methods that directly detect viral antigens in clinical sam- 
les without sample preparation is necessary for rapid and accu- 
ate diagnosis of the emerging pathogens. Basically, immunoassays 
re based on highly specific antigen-antibody interactions. The key 
o immunological diagnostic is immobilizing bioactive antibodies 
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Fig. 6. Representative examples of plasma engineering of drug/agent release coatings. (a) Single-step aerosol-assisted plasma deposition of gentamicin-containing coatings 
for drug release applications. Both continuous and pulsed mode plasma-exposed disks produced antimicrobial activity against Pseudomonas aeruginosa DSM939 and Staphy- 
lococcus aureus DSM799. The scanning electron microscopy (SEM) image shows the coating morphology which was prepared in the pulse mode for 20 min with 5 slm He, 
20 sccm ethylene, and 10 mg/mL gentamicin solution. The scale bar shows 1 μm. [126] , Copyright 2018. Adapted with permission from the American Chemical Society. (b) 
Multi-steps plasma surface engineering drug-loading processes and the relevant summary of the effects of the different plasma treatments performed to PP fibres on the 
adsorption of drugs and on the cell adhesion and morphology. [127] , Copyright 2015. Adapted with permission from Elsevier. (c) Gas-aggregation plasma sputtering system 
(1-vacuum flange, 2-aggregation chamber, 3-exit orifice, 4-water cooling, 5-gas inlet, 6-magnetron, 7-target, 8-electrical connection, 9-plasma, 10-beam of nanoparticles) for 
composite surfaces production with the capability of metal ions release and hydrophobic/superhydrophobic behaviour. Scale bars are 200 nm. [ 128 , 129 ]. [128] , Copyright 






























n support polymeric substrates by a protein-immobilization tech- 
ique to enable virus-capture and virus-detection. 
As discussed in Section 3.3.1 , plasma-based approaches are 
owerful tools for protein-immobilization that can retain the 
ioactivity of proteins on the test kit surfaces. Polymer sur- 
aces functionalized by plasma could effectively enhance the virus 
iosensor performance by enhancing immobilization of receptor 
ntibodies. For example, the sensitivity of a plasma functional- 
zed biosensor for human hepatitis B virus (HBV) is improved as 
uch as 10 0 0-fold in comparison with a commercial one [143] . Al-
hough relevant in-depth studies and commercial devices are rare, 
t is promising to develop new viral biosensors with enhanced per- 
ormance for detecting emerging pathogens using similar plasma 
unctionalization protocols [ 144 , 145 ]. Therefore, the development 
f novel viral biosensors by plasma surface functionalization is one 
f the important trends in antiviral applications. The key attention 
hould be on the relationships between the plasma treatment and w
10 he performance of the biosensors for future scalable production 
nd commercial devices. 
.2. Plasma-enabled new sanitizing approaches 
Clean air and common surfaces such as food packages, PPE, 
nd building elements without pathogens are essential for human 
ealth. Wet chemical solutions containing alcohol or hypochlorite 
re often used to mitigate pathogens in the air or on these com- 
on surfaces through spraying or wiping. However, the sanitizing 
pproach is labour- and materials-intensive, impractical for cover- 
ng all exposed areas, and needs to be periodically reapplied. In 
ddition, it may cause environmental pollution and then, in turn, 
egatively influence human health. Therefore, new sanitizing ap- 
roaches are required for creating a healthier living and working 
nvironment. 
One possible sanitizing approach is to collect virion-laden 
ater droplets in the air using plasma engineered hydrophilic- 

















































































































ydrophobic patterned polymers by taking advantage of the ca- 
acity of water-collection [146] , and then one can use physical 
ethods such as ultraviolet (UV) light, sunlight, and cold plasma 
tself to inactivate the viruses [ 93 , 147 ]. It should be emphasized
hat the UV sterilization can also be based on the utilization of 
old plasmas, with typical examples of the excimer- and Hg-lamps 
 148 , 149 ]. The challenge for such kind of sanitizing approach is the
nknown efficiency of the polymers collecting virion-laden water 
roplets in the air that needs to be precisely quantified. 
Self-sanitizing surfaces are ideal alternatives to the conventional 
anitizing approaches. Plasma engineered polymers with photocat- 
lytic self-cleaning [150–152] and/or water-repelling [153] proper- 
ies can be among the effective self-sanitizing surfaces. It is nec- 
ssary to pinpoint that the photocatalytic self-cleaning and super- 
ydrophobic water-repelling surfaces could be able to not only re- 
el the virion-laden respiratory droplets but also remove the de- 
ctivated or decomposed products. Typical examples of such bi- 
unctional self-sanitizing surfaces can be achieved by combining 
he superhydrophobic water-repelling polymer coatings with TiO 2 
anoparticles [154] . Moreover, plasma engineered superhydrophilic 
olymers could be useful for self-sanitizing applications to some 
xtent as they have theoretically shown the potential in reducing 
he risk of getting COVID-19 infection by reducing the dry time of 
he water droplets on them [52] . Another type of self-sanitizing 
urfaces can be plasma engineered chemically active coatings ca- 
able of RONS release and composite coatings capable of binding 
iruses or releasing antiviral drugs/agents [155–157] , as described 
n Section 3.2 and Section 3.3 , respectively. Such self-sanitizing 
oatings should be durable against rubbing and washing, long- 
asting, and nontoxic, which represent challenges for future stud- 
es. 
.3. Future antiviral polymers for future viruses 
As mentioned above, viruses evolve naturally, thus becoming 
ore aggressive to infect and/or more effective to kill. During the 
ast 20 years, various types of coronavirus including SARS-CoV, 
ERS-CoV, and SARS-CoV-2 have caused epidemics or pandemics, 
ith ACE2 being the primary receptor of SARS-CoV and SARS-CoV- 
 [1] , and CD26 mediating the entry of MERS-CoV [158] . These to-
ether with other receptors such as TMPRSS2 [159–161] that ac- 
ivate the spike protein of SARS-CoV, MERS-CoV, and SARS-CoV- 
, and CD209L [162] that mediates the entry of SARS-CoV, Ebola 
nd Sindbis, form the primary pool to predict the emerging highly 
revalent pathologic viruses (especially coronaviruses). The high 
ariety of the receptors and the mechanisms that lead to the entry 
f viruses into recipients pose a great challenge that complicates 
he development of specific drugs and vaccines for efficient viral 
isease control including COVID-19. 
Although drugs/vaccines against viral infection and multiplica- 
ion are the most efficient and canonical approaches for viral dis- 
ase management, their development is quite time-consuming and 
as a high risk to fail. The complexity of the specific drug develop- 
ent is also related to the fast evolution of the virus structure that 
an challenge the efficacy of medical treatment. SARS-CoV-2 has 
utated from type D614 to type G614 that is the current dominant 
ype in almost every nation and region affected by the COVID-19 
andemic [40] . 
To tackle challenges in the establishment of antiviral strategies 
gainst emerging viruses in the future, and challenges in the devel- 
pment of novel drugs as well as antiviral polymer surfaces, new 
pproaches and materials with broad-spectrum properties are re- 
uired [163] . Through computationally modelling virus-host recep- 
or interactions and identifying key factors affecting their recep- 
or binding affinities, one could predict the structure of potential 
iruses with enhanced transmission ability and corresponding an- 11 ibodies or antiviral drugs to prevent their potential spread. On the 
ther hand, an integrated pipeline or platform from initial compu- 
ational predictions of virus-host interactions to downstream poly- 
er fabrications including the plasma-assisted approach should be 
stablished for preventing emerging pandemics, which is of funda- 
ental significance to the public health and socio-economic devel- 
pment. 
. Conclusions and outlook 
The unpredictable nature of viral diseases and their impacts on 
he global economy and society pose a major challenge. Despite 
eing recognized as one of the most devastating global problems, 
tudies on the prevention and treatment of emerging viral diseases 
re sparse. The goal of this article is to provide a critical analysis of 
he recent progress in the field of plasma surface engineering for 
eveloping future polymer based antiviral surfaces. Several current 
nd emerging trends have been emphasized in the areas of poly- 
er science and surface engineering technology based on the use 
f plasma processing methods. 
Impressive recent advances in plasma functionalization of poly- 
er surfaces suggest that plasma-assisted surface functionalization 
pproaches are promising for the production of antiviral polymers 
ith targeted antiviral applications ranging from in-vitro preven- 
ion to in-vivo therapy. The strategy of antiviral polymers engi- 
eered by plasma processing such as biosensors and virus destruc- 
ion could be established in advance to respond to the next gener- 
tion of viruses and evolve faster than any emerging human viral 
athogens in the future. 
Ideally, the antiviral polymers for disease diagnosis, prevention 
nd therapeutics should be of a broad-spectrum activity against 
ultiple viruses and have multiple functionalities, i.e., in the form 
f a mixture of multiple types of plasma engineered polymers that 
ould be used for biosensing, disinfection and decontamination. 
mportantly, new approaches in antiviral polymers development 
ake advantage of computational predictions and are not limited 
o any particular type of viruses to cope with the fast evolution of 
iruses in practice. Considering major achievements in the manu- 
acturing of novel antibacterial surfaces using plasma surface engi- 
eering the hope in a fast translation of the available approaches 
or fighting against viruses is arguably high. However, practical 
mplementation of the highlighted trends will require a highly- 
oordinated cross-disciplinary collaboration involving researchers 
nd engineers from the areas spanning virology, bioinformatics, 
olymer science, and plasma surface engineering. 
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